Antipsychotics - Articles - Page 11

FDA Issues Alert for Geodon

February 1, 2015

In December 2014, the US Food and Drug Administration (FDA) issued a safety announcement warning that the antipsychotic drug ziprasidone (Geodon) has been associated with a rare but potentially fatal skin reaction.

The New FDA-Approved EEG Test for ADHD: Should You Order It?

December 1, 2014

Daniel Carlat, MD

Over the decades, finding a truly useful objective diagnostic test in psychiatry has proven both elusive and frustrating.

Table - Antipsychotic Medications Used for Children

December 1, 2014

Table: Antipsychotic Medications Used for Children (Click here to view as a full-size PDF.) ...

Table - Possible Side Effects of Antipsychotic Medications

December 1, 2014

Table: Possible Side Effects of Antipsychotic Medications (Click here to view as a full-size PDF.) ...

Using Antipsychotics Judiciously in Children

December 1, 2014

Glen Elliott, MD, PhD

Glen R. Elliott, MD, PhD
Chief Psychiatrist and Medical Director Children’s Health Council, Palo Alto, CA. Clinical Professor (Affiliated), Stanford University School of Medicine, Division of Child and Adolescent Psychiatry.
Dr. Elliott has disclosed that he has no relevant relationshipt or financial interests in any commercial company pertaining to this educational activity.

Read about the appropriate use of antipsychotics to treat disorders in children and adolescents, in an interview with psychiatrist Glen R. Elliott, MD, PhD.

Dealing With Side Effects of SSRIs

May 1, 2014

Pavan Madan, MD

Selective serotonin reuptake inhibitors (SSRIs) are widely used as the first-line treatment for depression and anxiety in children and adolescents, but they are associated with significant adverse effects (AEs). Studies have shown that up to 50% of kids experience side effects from SSRIs, depending on the sample size and the type of study.

Metabolic and Extrapyramidal Effects of Antipsychotics

May 1, 2014

Tamara Pringsheim, MD

Tamara Pringsheim, MD
Assistant Professor, Department of Clinical Neurosciences, Psychiatry, Pediatrics and Community Health Sciences University of Calgary.
Dr. Pringsheim has disclosed that she has been a paid consultant to Teva Neuroscience, Allergan, and Shire Canada. The editors have reviewed this interview and found no evidence of bias in this educational activity.

Pharmacoepidemiologist Tamara Pringsheim, MD, describes strategies for dealing with metabolic, extrapyramidal, and hormonal side effects of antipsychotics.

Glutamate’s Role in Schizophrenia

March 1, 2014

Steve Balt, MD, MS

Steve Balt, MD, MS Board Member, The Carlat Report. In private practice in the San Francisco Bay area. Dr. Balt discloses that his spouse is employed as a sales representative for Otsuka America.

There’s a rich history of research suggesting that glutamate may be involved in the pathogenesis of schizophrenia, with an increasing amount of attention being brought to glutamate during the past decade or so.

Lower Antipsychotic Use Linked to Better Outcomes

October 30, 2013

Section editor, Glen Spielmans, PhD

...

APA Warns Against Common Uses of Antipsychotics

October 1, 2013

In September, the American Psychiatric Association (APA) released a list of common, but potentially dangerous and inappropriate, uses for antipsychotics.